In this PCRS Health Inequalities podcast Katherine Hickman (PCRS executive chair, Kaniksha Aggarwal, Martin Sutcliffe and Sue Wheatcroft discuss respiratory disease and mental health in the context of the UK prison setting. They touch on:

PCRS are proud to have supported NHS England London’s #AskAboutAsthma campaign over the years.

With the summer holidays fast approaching, many will be planning trips abroad and booking flights for warm and sunny destinations. However, flying can be a very challenging way to travel for many people with respiratory disease.

Corinne Beirne, Advanced Nurse Practitioner and Amanda Roberts, from PCRS’s patient reference group, discuss what constitutes a good asthma review from a patient’s perspective.

2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.

As a summary, this policy statement advocates:

In this inspiring article we learn about the power of storytelling for children and young people suffering from asthma. Asthma is a very common disease, and for some it is a lifelong condition requiring long-term self-management.

In a time of uncertainty and financial pressure, this issue of Primary Care Respiratory Update (PCRU) is a vital resource for anyone working in respiratory care. As Integrated Care Boards across England face significant budget cuts, programmes that have taken years to build are now under threat.

For our next In Conversation Katherine was joined by Dr Richard Russell, a man of many respiratory interested hats!

Joining us on Wednesday 21st May, 19:30-20:00, for our next In Conversation is Dr Richard Russell, a man of many respiratory interested hats!

In November 2024 NICE, in collaboration the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN), released guidance NG245.

In this podcast Fiona Mosgrove (PCRS Education lead) and Tom Fardon (Consultant Physician) discuss asthma biologics and how they can support effective severe asthma care.

Are you struggling to persuade your Integrated Care Board (ICB) to fund FeNO testing? With the new BTS/NICE/SIGN asthma guideline recommending FeNO for asthma diagnostic testing, this can create quite a challenging for primary care providers.

The Medicines and Healthcare products Regulatory Agency (MHRA) has put out a reminder for healthcare professionals and patients with asthma that overuse of blue inhalers (short-acting beta 2 agonists or SABAs), without use of a preventer inhaler, may lead to worsening symptoms or serious asthma a

Join Dr Sanjeev Rana and Dr Katherine Hickman on Wednesday 30th April from 19:00 for a focused, practical session offering clear, evidence-based guidance on when to use FeNO testing to support asthma diagnosis.